Review



erk mapk inhibitor fr 180204  (Beyotime)


Bioz Verified Symbol Beyotime is a verified supplier
Bioz Manufacturer Symbol Beyotime manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
    • 90
      Buy from Supplier

    Structured Review

    Beyotime erk mapk inhibitor fr 180204
    Erk Mapk Inhibitor Fr 180204, supplied by Beyotime, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/erk+mapk+inhibitor+fr+180204/fr180204/pmc11234033-144-19-24
    Average 90 stars, based on 1 article reviews
    erk mapk inhibitor fr 180204 - by Bioz Stars, 2026-10
    90/100 stars

    Images

    Related Articles

    MTT Assay:

    Article Title: Temporary alleviation of MAPK by arbutin alleviates oxidative damage in the retina and ARPE-19 cells
    Article Snippet: Before pretreatment with 10, 25, 50, 100, 250 or 500 μM ARB for 24 h, cells were treated with FR 180204 (ERK MAPK inhibitor, Beyotime, Shanghai, China) or SB203580 (p38 MAPK inhibitor, Beyotime) for 1 h, and then they were treated with 600 μM H 2 O 2 for 24 h or treated with 100, 200, 300, 400, 500, 600 or 700 μM H 2 O 2 alone for 24 h. Next, 30 μl of 5 % MTT solution was added, and the plate was incubated at 37 °C for 2 h. Then, 150 μl of DMSO was added, and the absorbance of each well was measured at 490 nm for comparison.

    Incubation:

    Article Title: Temporary alleviation of MAPK by arbutin alleviates oxidative damage in the retina and ARPE-19 cells
    Article Snippet: Before pretreatment with 10, 25, 50, 100, 250 or 500 μM ARB for 24 h, cells were treated with FR 180204 (ERK MAPK inhibitor, Beyotime, Shanghai, China) or SB203580 (p38 MAPK inhibitor, Beyotime) for 1 h, and then they were treated with 600 μM H 2 O 2 for 24 h or treated with 100, 200, 300, 400, 500, 600 or 700 μM H 2 O 2 alone for 24 h. Next, 30 μl of 5 % MTT solution was added, and the plate was incubated at 37 °C for 2 h. Then, 150 μl of DMSO was added, and the absorbance of each well was measured at 490 nm for comparison.

    Comparison:

    Article Title: Temporary alleviation of MAPK by arbutin alleviates oxidative damage in the retina and ARPE-19 cells
    Article Snippet: Before pretreatment with 10, 25, 50, 100, 250 or 500 μM ARB for 24 h, cells were treated with FR 180204 (ERK MAPK inhibitor, Beyotime, Shanghai, China) or SB203580 (p38 MAPK inhibitor, Beyotime) for 1 h, and then they were treated with 600 μM H 2 O 2 for 24 h or treated with 100, 200, 300, 400, 500, 600 or 700 μM H 2 O 2 alone for 24 h. Next, 30 μl of 5 % MTT solution was added, and the plate was incubated at 37 °C for 2 h. Then, 150 μl of DMSO was added, and the absorbance of each well was measured at 490 nm for comparison.



    Similar Products

    erk mapk inhibitor fr 180204  (Beyotime)
    90
    Beyotime erk mapk inhibitor fr 180204
    Erk Mapk Inhibitor Fr 180204, supplied by Beyotime, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/erk+mapk+inhibitor+fr+180204/fr180204/pmc11234033-144-19-24
    Average 90 stars, based on 1 article reviews
    erk mapk inhibitor fr 180204 - by Bioz Stars, 2026-10
    90/100 stars
    		  Buy from Supplier
    erk mapk inhibitor type entrez nucleotide attrs text fr180204 term id 258307209 term text fr180204  (MedChemExpress)
    95
    MedChemExpress erk mapk inhibitor type entrez nucleotide attrs text fr180204 term id 258307209 term text fr180204
    SHMT2 promotes breast cancer cell proliferation by activating MAPK pathway. Western blotting analysis of proteins with phosphorylation or not related in MAPK signaling pathway in breast cancer cells with SHMT2 knockdown (A) and over-expression (B). Cell viability was analyzed by MTT assay in HCC1806 cells with SHMT2 knockdown treated with an ERK inhibitor <t>FR180204</t> (C) or a p38 inhibitor SB202190 (D). ZR-75-1 cells with SHMT2 overexpression were treated with an ERK inhibitor FR180204 (E) or a p38 inhibitor SB202190 (F). # represents the comparison between inhibitor plus SHMT2 over-expression group and SHMT2 over-expression group. * represents the comparison between treatment group and control group. #, *P < 0.05. Student’s t-test. The data are presented as the mean ± SD. The error bars show the SD.
    Erk Mapk Inhibitor Type Entrez Nucleotide Attrs Text Fr180204 Term Id 258307209 Term Text Fr180204, supplied by MedChemExpress, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/erk+mapk+inhibitor+fr+180204/FR+180204/pmc09360240-60-0-15
    Average 95 stars, based on 1 article reviews
    erk mapk inhibitor type entrez nucleotide attrs text fr180204 term id 258307209 term text fr180204 - by Bioz Stars, 2026-10
    95/100 stars
    		  Buy from Supplier
    erk mapk inhibitor fr180204  (MedChemExpress)
    95
    MedChemExpress erk mapk inhibitor fr180204
    SHMT2 promotes breast cancer cell proliferation by activating MAPK pathway. Western blotting analysis of proteins with phosphorylation or not related in MAPK signaling pathway in breast cancer cells with SHMT2 knockdown (A) and over-expression (B). Cell viability was analyzed by MTT assay in HCC1806 cells with SHMT2 knockdown treated with an ERK inhibitor <t>FR180204</t> (C) or a p38 inhibitor SB202190 (D). ZR-75-1 cells with SHMT2 overexpression were treated with an ERK inhibitor FR180204 (E) or a p38 inhibitor SB202190 (F). # represents the comparison between inhibitor plus SHMT2 over-expression group and SHMT2 over-expression group. * represents the comparison between treatment group and control group. #, *P < 0.05. Student’s t-test. The data are presented as the mean ± SD. The error bars show the SD.
    Erk Mapk Inhibitor Fr180204, supplied by MedChemExpress, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/erk+mapk+inhibitor+fr+180204/FR+180204/pmc09360240-130-0-14
    Average 95 stars, based on 1 article reviews
    erk mapk inhibitor fr180204 - by Bioz Stars, 2026-10
    95/100 stars
    		  Buy from Supplier

    Image Search Results


    SHMT2 promotes breast cancer cell proliferation by activating MAPK pathway. Western blotting analysis of proteins with phosphorylation or not related in MAPK signaling pathway in breast cancer cells with SHMT2 knockdown (A) and over-expression (B). Cell viability was analyzed by MTT assay in HCC1806 cells with SHMT2 knockdown treated with an ERK inhibitor FR180204 (C) or a p38 inhibitor SB202190 (D). ZR-75-1 cells with SHMT2 overexpression were treated with an ERK inhibitor FR180204 (E) or a p38 inhibitor SB202190 (F). # represents the comparison between inhibitor plus SHMT2 over-expression group and SHMT2 over-expression group. * represents the comparison between treatment group and control group. #, *P < 0.05. Student’s t-test. The data are presented as the mean ± SD. The error bars show the SD.

    Journal: American Journal of Cancer Research

    Article Title: SHMT2 promotes tumor growth through VEGF and MAPK signaling pathway in breast cancer

    doi:

    Figure Lengend Snippet: SHMT2 promotes breast cancer cell proliferation by activating MAPK pathway. Western blotting analysis of proteins with phosphorylation or not related in MAPK signaling pathway in breast cancer cells with SHMT2 knockdown (A) and over-expression (B). Cell viability was analyzed by MTT assay in HCC1806 cells with SHMT2 knockdown treated with an ERK inhibitor FR180204 (C) or a p38 inhibitor SB202190 (D). ZR-75-1 cells with SHMT2 overexpression were treated with an ERK inhibitor FR180204 (E) or a p38 inhibitor SB202190 (F). # represents the comparison between inhibitor plus SHMT2 over-expression group and SHMT2 over-expression group. * represents the comparison between treatment group and control group. #, *P < 0.05. Student’s t-test. The data are presented as the mean ± SD. The error bars show the SD.

    Article Snippet: ERK MAPK inhibitor {"type":"entrez-nucleotide","attrs":{"text":"FR180204","term_id":"258307209","term_text":"FR180204"}} FR180204 (HY-12275), p38 MAPK inhibitor SB202190 (HY-10295) were purchased from the Med Chem Express (MCE).

    Techniques: Western Blot, Over Expression, MTT Assay